Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery

Protein Expression and Purification

Volumn 110, Issue , 2015, Pages 52-56

  Murata, Masaharu ^a,b   Piao, Jing Shu ^a   Narahara, Sayoko ^a,b   Kawano, Takahito ^a,b   Hamano, Nobuhito ^a   Kang, Jeong Hun ^c   Asai, Daisuke ^d   Ugawa, Ryo ^b   Hashizume, Makoto ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B virus; Ferritin; Hepatitis; Myristoylation; Protein cage; Targeted delivery

Indexed keywords

CERCOPITHECINE HERPESVIRUS 1; ESCHERICHIA COLI;

ACYLTRANSFERASE; FERRITIN; FUNGAL PROTEIN; GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; MYRISTIC ACID; PRESURFACE PROTEIN 1, HEPATITIS B SURFACE ANTIGEN; PROTEIN BINDING; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC ENGINEERING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL; METABOLISM; MOLECULAR CLONING; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PLASMID; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

ACYLTRANSFERASES; CELL LINE; CLONING, MOLECULAR; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; FERRITINS; FUNGAL PROTEINS; GENE EXPRESSION; GENETIC ENGINEERING; HEPATITIS B SURFACE ANTIGENS; HEPATOCYTES; HUMANS; MOLECULAR TARGETED THERAPY; MYRISTIC ACID; PLASMIDS; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 84923633688     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2014.12.001     Document Type: Article

References (21)

1. C.T. Walsh, S. Garneau-Tsodikova, and G.J. Gatto Jr. Protein posttranslational modifications: the chemistry of proteome diversifications Angew. Chem. Int. Ed. 44 2005 7342 7372
2. R.N. Hannoush, and J. Sun The chemical toolbox for monitoring protein fatty acylation and prenylation Nat. Chem. Biol. 6 2010 498 506
3. M.D. Resh Trafficking and signaling by fatty-acylated and prenylated proteins Nat. Chem. Biol. 2 2006 584 590
4. K. Sao, M. Murata, Y. Fujisaki, K. Umezaki, T. Mori, T. Niidome, Y. Katayama, and M. Hashizume A novel protease activity assay using a protease-responsive chaperone protein Biochem. Biophys. Res. Commun. 383 2009 293 297
5. K. Sao, M. Murata, K. Umezaki, Y. Fujisaki, T. Mori, T. Niidome, Y. Katayama, and M. Hashizume Molecular design of protein-based nanocapsules for stimulus-responsive characteristics Biorg. Med. Chem. 17 2009 85 93
6. M. Murata, S. Narahara, K. Umezaki, R. Toita, S. Tabata, J.S. Piao, K. Abe, J.H. Kang, K. Ohuchida, L. Cui, and M. Hashizume Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages Int. J. Nanomed. 7 2012 4353 4362
7. R. Toita, M. Murata, S. Tabata, K. Abe, S. Narahara, J.S. Piao, J.H. Kang, and M. Hashizume Development of human hepatocellular carcinoma cell-targeted protein cages Bioconjug. Chem. 23 2012 1494 1501
8. R. Toita, M. Murata, K. Abe, S. Narahara, J.S. Piao, J.H. Kang, and M. Hashizume A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells Chem. Commun. 49 2013 7442 7444
9. R. Toita, M. Murata, K. Abe, S. Narahara, J.S. Piao, J.H. Kang, K. Ohuchida, and M. Hashizume Biological evaluation of protein nanocapsules containing doxorubicin Int. J. Nanomed. 8 2013 1989 1999
10. J.H. Kang, R. Toita, D. Asai, T. Yamaoka, and M. Murata Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus J. Virol. Methods 201 2014 20 23
11. Y.J. Yang, P.S. Zhao, H.X. Wu, H.L. Wang, L.L. Zhao, X.H. Xue, W.W. Gai, Y.W. Gao, S.T. Yang, and X.Z. Xia Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29) Protein Expr. Purif. 104C 2014 7 13
12. X. Zhao, Y. Dong, Z. Zhao, J. Guo, J. Liu, P. Huang, D. Dong, H. Fan, Q. Guo, X. Yang, J. Xu, J. Li, L. Fu, and W. Chen Intracellular delivery of artificial transcription factors fused to the protein transduction domain of HIV-1 Tat Protein Expr. Purif. 90 2013 27 33
13. J. Jung, M. Iijima, N. Yoshimoto, M. Sasaki, T. Niimi, K. Tatematsu, S.Y. Jeong, E.K. Choi, K. Tanizawa, and S. Kuroda Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae Protein Expr. Purif. 78 2011 149 155
14. D. Glebe, S. Urban, E.V. Knoop, N. Ça, P. Krass, S. Grün, A. Bulavaite, K. Sasnauskas, and W.H. Gerlich Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes Gastroenterology 129 2005 234 245
15. T. Muller, S. Mehrle, A. Schieck, U. Haberkorn, S. Urban, and W. Mier Liver imaging with a novel hepatitis B surface protein derived SPECT-tracer Mol. Pharm. 10 2013 2230 2236
16. K. Hintze, and E. Theil Cellular regulation and molecular interactions of the ferritins Cell. Mol. Life Sci. 63 2006 591 600
17. Z. Wang, C. Li, M. Ellenburg, E. Soistman, J. Ruble, B. Wright, J.X. Ho, and D.C. Carter Structure of human ferritin L chain Acta Crystallogr. D Biol. Crystallogr. 62 2006 800 806
18. S. Maurer-Stroh, and F. Eisenhaber Myristoylation of viral and bacterial proteins Trends Microbiol. 12 2004 178 185
19. D.D. Martin, E. Beauchamp, and L.G. Berthiaume Post-translational myristoylation: fat matters in cellular life and death Biochimie 93 2011 18 31
20. A. Arzumanyan, H.M. Reis, and M.A. Feitelson Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Nat. Rev. Cancer 13 2013 123 135
21. A. Meier, S. Mehrle, T.S. Weiss, W. Mier, and S. Urban Myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes Hepatology 58 2013 31 42